Modeling cognition and disease using human glial chimeric mice.
- Authors
- Goldman, Steven A; Nedergaard, Maiken; Windrem, Martha S
- Year
- 2015
- Journal
- Glia
- PMID
- 26010831
- DOI
- 10.1002/glia.22862
- PMCID
- PMC4527525
As new methods for producing and isolating human glial progenitor cells (hGPCs) have been developed, the disorders of myelin have become especially compelling targets for cell-based therapy. Yet as animal modeling of glial progenitor cell-based therapies has progressed, it has become clear that transplanted hGPCs not only engraft and expand within murine hosts, but dynamically outcompete the resident progenitors so as to ultimately dominate the host brain. The engrafted human progenitor cells proceed to generate parenchymal astrocytes, and when faced with a hypomyelinated environment, oligodendrocytes as well. As a result, the recipient brains may become inexorably humanized with regards to their resident glial populations, yielding human glial chimeric mouse brains. These brains provide us a fundamentally new tool by which to assess the species-specific attributes of glia in modulating human cognition and information processing. In addition, the cellular humanization of these brains permits their use in studying glial infectious and inflammatory disorders unique to humans, and the effects of those disorders on the glial contributions to cognition. Perhaps most intriguingly, by pairing our ability to construct human glial chimeras with the production of patient-specific hGPCs derived from pluripotential stem cells, we may now establish mice in which a substantial proportion of resident glia are both human and disease-derived. These mice in particular may provide us new opportunities for studying the human-specific contributions of glia to psychopathology, as well as to higher cognition. As such, the assessment of human glial chimeric mice may provide us new insight into the species-specific contributions of glia to human cognitive evolution, as well as to the pathogenesis of human neurological and neuropsychiatric disease.
Human glial progenitors can colonize and fully myelinate the hypomyelinated mouse CNSA–B. Sagittal images of an immmunodeficient shiverer mouse brain (MBP shi/shi x rag2−/−), sacrificed at 1 year after neonatal transplant of hGPCs. Each image in A and B represents a montage of 50 to 100 individual 10x photomicrographs; each series begins 750 μm lateral to the midline and continues at 600 μm intervals. A. Human donor cells, immunolabeled in 14 μm cryosections using an anti-human nuclear antibody (hN; red). B Myelin basic protein (MBP; green) in sections adjacent or nearly so to their matched sections in A. C. Donor-derived MBP (green) in the spinal cord at 1 year, at the level of the conus medullaris. D shows a Kaplan-Meier plot of the effect of neonatal hGPC engraftment upon the survival of these mice. Shiverer x rag2−/− mice were either engrafted at birth with hGPCs (n=26, red), injected with saline (n = 29, green), or not treated (n=59, blue). Whereas all control mice died between 18 and 21 weeks of age, a fraction of engrafted mice lived substantially longer than any controls; some were frankly rescued, with concomitant recovery of neurological phenotype as well. The experiment was terminated at 13 months, and rescued mice were sacrificed for observation through 2 years of age. Scale: 200 μm.A, B and D from (Windrem et al. 2008).
Human GPCs out-compete and ultimately replace resident mouse GPCsA. Human glial progenitor cells (hGPCs), neonatally transplanted into either congenitally hypomyelinated shiverer x rag2−/− (left column) or normally myelinated rag2−/− (right column) mouse brain, disperse and expand broadly throughout the brain as a function of age. hGPCs reach higher density in white matter than gray matter of the hypomyelinated shiverer (left), in contrast to their relatively uniform distribution in normally myelinated brain (right). Red dots indicate individual human donor GPCs, as labeled by human nuclear antigen (left and right columns). B. Progressive replacement of host mouse GPCs, by donor hGPCs, as identified by species-specific antibodies against NG2, compared to an unengrafted control mouse (left-most column). By one year, hGPCs have replaced mouse GPCs throughout the entire depth of the cortex. C. EGFP-tagged human astrocytes in the corpus callosum, cortex, and fimbria in a 2-year old rag2−/− mouse. The hGPCs were labeled with an EGFP-expressing lentivirus (green) in vitro, prior to transplantation. Dorsal is toward the top and rostral to the left in this sagittal section. (EGFP, green; human-specific GFAP, red). Scale: 100 μm.A and B, from (Windrem et al. 2014).
Human glial chimeras manifest enhanced long-term potentiation and learn more rapidlyA. Induction of LTP by two trains of high-frequency stimulation (each train consisted of 100 pulses at 100 Hz, with 30 s between bursts) in human chimeric mice, but not in unengrafted littermates or mice allografted with conspecific mouse GPCs (n=7 mice/group, *p<0.05; t-test compares fEPSP slopes before and 60 min after stimulation, for each group). B. Object-Location Memory Task (OLT) in chimeric mice and their unengrafted rag1 null littermate controls demonstrated a learning advantage in chimeric mice, via enhanced recognition of and preference for the novel displaced object (n=7, **p<0.01, one-way ANOVA). C. Auditory fear conditioning assessed in a cohort of human glial chimeric, mouse allografted, and unengrafted rag2−/− control mice. The human glial chimeric mice exhibit prolonged freezing behavior in test chamber 2 during exposure to the tonal conditioned stimulus, when compared to their unengrafted mice and allografted controls (n=5–20, *p<.05, **p<0.01, 2-way repeated-measures ANOVA with Bonferroni t-tests). D. Barnes maze testing in chimeric and unengrafted immunodeficient littermate controls. Chimeric mice demonstrated a significant learning advantage, as reflected in a shorted latency and fewer errors in solving the maze (n=6, *p<0.05, **p,0.01, 2-way ANOVA with Bonferroni t-tests).From (Han et al. 2013).
Neonatal engraftment with hiPSC GPCs produces patient-specific human glial chimerasConfocal images of the callosal and capsular white matter of shiverer mice neonatally engrafted with hiPSC OPCs produced from hiPSCs derived from 3 independent patient-derived lines, designated C27 (A–D); K04 (E–H); and C14 (I–K). A, G, and J show abundant, donor-derived myelin basic protein expression (MBP, green) by C27, K04, and C14 hiPSC hGPCs (hNA, red), respectively. Representative z stacks of individual hNA+ oligodendroglia are shown as asterisks in A and E. By 19 weeks, hiPSC oligodendroglia derived from all 3 lines (B, C27; E–F, K04; J, C14) robustly myelinated axons (neurofilament, red). hiPSC-derived oligodendroglial morphologies are exemplified in panels F (K04) and I (C14); F in particular shows multi-axon myelination by single oligodendroglia in the striatum. hiPSC hGPCs also generated astroglia (C, C27; H, K04), which exhibited the complex fibrous morphologies typical of human astrocytes (human-specific GFAP, green). Many cells also remained as progenitors, immunostaining for NG2 (D, C27) or PDGFαR (K, C14). Scale: 50 μm (A–C, G, J); 20 μm (C–F, H, K); and 10 μm (I, insets to A and E).From (Wang et al. 2013).
Human glial chimeric mice can develop a prototypic human viral encephalitisJCV infection and spread in vivo was tracked by immunostaining human glial-engrafted shiverer brains for the late viral VP1 antigen, as a function of time after infection. In these chimeric shiverers, essentially all myelinating oligodendrocytes, as well as most GPCs and large numbers of astrocytes, are human. A–B, By 4 weeks after infection by the polyomavirus JCV, focal regions of demyelination (A, arrows) and infection-associated astrogliosis (B, arrow) are noted in the forebrain white matter of human glial chimeric mice, typically abutting the callosal wall of the lateral ventricle. C, By 11 weeks after infection, diffuse hypomyelination of the corpus callosa and capsules of infected chimeric mice was noted. D, Sagittal sections of 3 different infected chimeras at each of 3 time-points are shown; individual VP1+ cells are dot-mapped onto the schematic. VP1+ human cells became progressively more widespread with time, with JCV infection progressing from the site of viral injection to include much of the forebrain white matter by 12 weeks post-infection, with marked cortical spread by that point as well. Scale: 200 μm (A, C); 100 μm (B).From (Kondo et al. 2014).
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Exploring the Expanded Role of Astrocytes in Primate Brain Evolution via Changes in Gene Expression. | Rickelton K et al. | — | 2025 | → |
| Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation. | Siffrin V | — | 2025 | → |
| Astrocyte-Mediated Neuroinflammation in Neurological Conditions. | Zhao Y et al. | — | 2024 | → |
| Emerging Human Pluripotent Stem Cell-Based Human-Animal Brain Chimeras for Advancing Disease Modeling and Cell Therapy for Neurological Disorders. | Ji Y et al. | — | 2024 | → |
| Human-mouse chimeric brain models constructed from iPSC-derived brain cells: Applications and challenges. | Zhao Y et al. | — | 2024 | → |
| Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain. | Vieira R et al. | — | 2024 | → |
| Glial progenitor cells of the adult human white and grey matter are contextually distinct. | Osorio MJ et al. | — | 2023 | → |
| Human-Pig Chimeric Organ in Organ Transplantation from Islamic Bioethics Perspectives. | Mohd Zailani MF et al. | — | 2023 | → |
| Neurodegeneration cell per cell. | Balusu S et al. | — | 2023 | → |
| The Journey of iPSC-derived OPCs in Demyelinating Disorders: From <i>In vitro</i> Generation to <i>In vivo</i> Transplantation. | Lohrasbi F et al. | — | 2023 | → |
| Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkers. | Maalouf KE et al. | — | 2023 | → |
| A perspective on astrocyte regulation of neural circuit function and animal behavior. | Hirrlinger J et al. | — | 2022 | → |
| Astrocyte Progenitors Derived From Patients With Alzheimer Disease Do Not Impair Stroke Recovery in Mice. | Välimäki NN et al. | — | 2022 | → |
| The elusive varicose astrocytes. | Rasmussen RN et al. | — | 2022 | → |
| Glial progenitor cell-based repair of the dysmyelinated brain: Progression to the clinic. | Goldman SA et al. | — | 2021 | → |
| Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials. | Sutiwisesak R et al. | — | 2021 | → |
| Glial evolution as a determinant of human behavior and its disorders. | Goldman SA | — | 2020 | → |
| Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms. | Oksanen M et al. | — | 2019 | → |
| Ethical considerations for human-animal neurological chimera research: mouse models and beyond. | Hyun I | — | 2019 | → |
| Human Glial Chimeric Mice to Define the Role of Glial Pathology in Human Disease. | Mariani JN et al. | — | 2019 | → |
| Human-Monkey Chimeras for Modeling Human Disease: Opportunities and Challenges. | De Los Angeles A et al. | — | 2019 | → |
| PD-1 Dynamically Regulates Inflammation and Development of Brain-Resident Memory CD8 T Cells During Persistent Viral Encephalitis. | Shwetank et al. | — | 2019 | → |
| Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective. | Dalvi S et al. | — | 2019 | → |
| Uses for humanised mouse models in precision medicine for neurodegenerative disease. | Nair RR et al. | — | 2019 | → |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | — | 2019 | → |
| Human-Monkey Chimeras for Modeling Human Disease: Opportunities and Challenges. | De Los Angeles A et al. | — | 2018 | → |
| Astroglial hydro-ionic waves guided by the extracellular matrix: An exploratory model. | Pereira A | — | 2017 | → |
| Human astrocytes are distinct contributors to the complexity of synaptic function. | Krencik R et al. | — | 2017 | → |
| Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia. | Windrem MS et al. | — | 2017 | → |
| Molecular mechanisms of astrocyte-induced synaptogenesis. | Baldwin KT et al. | — | 2017 | → |
| Sensory response in host and engrafted astrocytes of adult brain in Vivo. | Zhang K et al. | — | 2017 | → |
| Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains. | Li W et al. | — | 2017 | → |
| Glial progenitor cell-based treatment of the childhood leukodystrophies. | Osorio MJ et al. | — | 2016 | → |
| Humanized neuronal chimeric mouse brain generated by neonatally engrafted human iPSC-derived primitive neural progenitor cells. | Chen C et al. | — | 2016 | → |
| In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells. | Korecka JA et al. | — | 2016 | → |
| On Having No Head: Cognition throughout Biological Systems. | Baluška F et al. | — | 2016 | → |
| Spatial organization of astrocytes in ferret visual cortex. | López-Hidalgo M et al. | — | 2016 | → |
| How to make an oligodendrocyte. | Goldman SA et al. | — | 2015 | → |
| The stability of memories during brain remodeling: A perspective. | Blackiston DJ et al. | — | 2015 | → |